Sagres Discovery, Inc.
9Patents
3Active
9Granted
33Portfolio score
Filing activity: Dec 26, 2001 → Apr 7, 2006 · 3 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7919246B2 | SEMA4D in cancer diagnosis, detection and treatment | Physics | 28 | Expired |
| US7892730B2 | Compositions and methods for cancer | Emerging Cross-Sectional Technologies | 13 | Active |
| US7820447B2 | Compositions and methods for cancer | Emerging Cross-Sectional Technologies | 8 | Active |
| US7332281B2 | Therapeutic targets in cancer | Chemistry; Metallurgy | 4 | Expired |
| US7767387B2 | Therapeutic targets in cancer | Emerging Cross-Sectional Technologies | 1 | Expired |
| US7700274B2 | Compositions and methods in cancer associated with altered expression of KCNJ9 | Chemistry; Metallurgy | 0 | Expired |
| US7816076B2 | Therapeutic targets in cancer | Chemistry; Metallurgy | 0 | Expired |
| US8252267B2 | DKKL-1 splice product modulators for cancer diagnosis and therapy | Chemistry; Metallurgy | 0 | Active |
| US7645441B2 | Compositions and methods in cancer associated with altered expression of PRLR | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.